These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 32732924)

  • 41. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A review of respiratory manifestations and their management in Ehlers-Danlos syndromes and hypermobility spectrum disorders.
    Chohan K; Mittal N; McGillis L; Lopez-Hernandez L; Camacho E; Rachinsky M; Mina DS; Reid WD; Ryan CM; Champagne KA; Orchanian-Cheff A; Clarke H; Rozenberg D
    Chron Respir Dis; 2021; 18():14799731211025313. PubMed ID: 34291699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome.
    Forghani I
    Balkan Med J; 2019 Jan; 36(1):12-16. PubMed ID: 30063214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ehlers-Danlos syndrome presenting as dysphonia and manifesting as tongue hypermobility: Report of 2 cases.
    Richmon JD; Wang-Rodriguez J; Thekdi AA
    Ear Nose Throat J; 2009 Feb; 88(2):E8-12. PubMed ID: 19224471
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Healthcare utilization among youth with Ehlers-Danlos syndrome hypermobile type.
    Williams SE; Tran ST; Lynch-Jordan A; Goldschneider KR; Ting TV; Kashikar-Zuck S; Neilson D
    Am J Med Genet A; 2022 Apr; 188(4):1109-1117. PubMed ID: 34989147
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bleeding and bruising in patients with Ehlers-Danlos syndrome and other collagen vascular disorders.
    De Paepe A; Malfait F
    Br J Haematol; 2004 Dec; 127(5):491-500. PubMed ID: 15566352
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastrointestinal disorders in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type: A review for the gastroenterologist.
    Beckers AB; Keszthelyi D; Fikree A; Vork L; Masclee A; Farmer AD; Aziz Q
    Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28086259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ehlers-Danlos syndrome IV: phenotype variation].
    Engels CH; van Dongen PW; Boers GH; Steijlen PM; Hamel BC
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):296-8. PubMed ID: 9148166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Ehlers-Danlos syndrome, a disorder with many faces.
    De Paepe A; Malfait F
    Clin Genet; 2012 Jul; 82(1):1-11. PubMed ID: 22353005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ehlers-Danlos syndrome: insights on obstetric aspects.
    Volkov N; Nisenblat V; Ohel G; Gonen R
    Obstet Gynecol Surv; 2007 Jan; 62(1):51-7. PubMed ID: 17176488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Entrapment neuropathies and polyneuropathies in joint hypermobility syndrome/Ehlers-Danlos syndrome.
    Granata G; Padua L; Celletti C; Castori M; Saraceni VM; Camerota F
    Clin Neurophysiol; 2013 Aug; 124(8):1689-94. PubMed ID: 23743406
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ehlers-Danlos syndrome associated with glycosaminoglycan abnormalities.
    Miyake N; Kosho T; Matsumoto N
    Adv Exp Med Biol; 2014; 802():145-59. PubMed ID: 24443026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of narrative medicine in the management of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Knight I
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):123-9. PubMed ID: 25821096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical presentation of Ehlers-Danlos syndrome.
    Lawrence EJ
    Adv Neonatal Care; 2005 Dec; 5(6):301-14. PubMed ID: 16338669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification.
    Hausser I; Anton-Lamprecht I
    Hum Genet; 1994 Apr; 93(4):394-407. PubMed ID: 8168810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generalized joint hypermobility, joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Colombi M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):1-5. PubMed ID: 25821089
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing.
    Cortini F; Villa C; Marinelli B; Combi R; Pesatori AC; Bassotti A
    Arch Dermatol Res; 2019 May; 311(4):265-275. PubMed ID: 30826961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Respiratory manifestations of Ehlers-Danlos syndromes].
    Benattia A; Benistan K; Frank M; Boussouar S
    Rev Mal Respir; 2023 Mar; 40(3):254-264. PubMed ID: 36740495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ruptured dissecting aneurysm in bilateral iliac arteries caused by Ehlers-Danlos syndrome type IV: report of a case.
    Imamura A; Nakamoto H; Inoue T; Yamada H; Okuno M; Takai S; Komada H; Kwon AH; Kamiyama Y
    Surg Today; 2001; 31(1):85-9. PubMed ID: 11213052
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ehlers-Danlos Syndrome, classical type: case management.
    Whitelaw SE
    Pediatr Nurs; 2003; 29(6):423-6. PubMed ID: 14743836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.